Rocket Pharmaceuticals, Inc.
RCKT· Nasdaq
Released Nov 6, 2025, after the close
10-Q filed Nov 6, 2025, 37 days after period end · 0001193125-25-269474
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$50.33M | -$66.72M | -$61.90M | -$57.76M |
| EPS Diluted |
Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR
| -$0.45 |
| -$0.71 |
| -$0.75 |
| -$0.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.